For GSK Nigeria, this development is laden with layers of complexity, driven by a mix of internal challenges within the company and external factors. Still, how it is perceived and the implications do not translate well for Nigeria, especially in terms of unemployment and human capital development. Renowned for products such as Panadol, Lucozade, Ribena, […]
The post GSK Nigeria: A signalled exit or corporate intrigues?, By Cheta Nwanze appeared first on Premium Times Nigeria.
